APA (7th ed.) Citation

Rubio‐Rivas, M., Forero, C. G., Mora‐Luján, J. M., Montero, A., Formiga, F., Homs, N. A., . . . Corbella, X. (2021). Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. Pharmacotherapy, 41(11), 884. https://doi.org/10.1002/phar.2627

Chicago Style (17th ed.) Citation

Rubio‐Rivas, Manuel, et al. "Beneficial and Harmful Outcomes of Tocilizumab in Severe COVID‐19: A Systematic Review and Meta‐analysis." Pharmacotherapy 41, no. 11 (2021): 884. https://doi.org/10.1002/phar.2627.

MLA (9th ed.) Citation

Rubio‐Rivas, Manuel, et al. "Beneficial and Harmful Outcomes of Tocilizumab in Severe COVID‐19: A Systematic Review and Meta‐analysis." Pharmacotherapy, vol. 41, no. 11, 2021, p. 884, https://doi.org/10.1002/phar.2627.